Oxford Index Search Results

You are looking at 1-20 of 25 items for:

disopyramide x clear all

disopyramide

Overview page. Subjects: Clinical Pharmacology and Therapeutics.

A type 1 antiarrhythmic drug that acts directly on cardiac muscle depolarization and has no effect on α- or β-adrenergic receptors. TN Norpace.

See overview in Oxford Index

disopyramide

Overview page. Subjects: Clinical Pharmacology and Therapeutics.

A type 1 antiarrhythmic drug that acts directly on cardiac muscle depolarization and has no effect on α- or β-adrenergic receptors. TN Norpace.

See overview in Oxford Index

disopyramide

John Lackie.

in A Dictionary of Biomedicine

January 2010; p ublished online January 2010 .

Reference Entry. Subjects: Clinical Medicine. 24 words.

A type 1 antiarrhythmic drug that acts directly on cardiac muscle depolarization and has no effect on α- or β-adrenergic

Go to Oxford Reference »  home page

disopyramide

in Concise Medical Dictionary

January 2010; p ublished online January 2010 .

Reference Entry. Subjects: Medicine and Health. 37 words.

n. an *anti-arrhythmic drug used to treat supraventricular and ventricular arrhythmias. It is administered by mouth or injection; side-effects

Go to Oxford Reference »  home page

disopyramide <i>n.</i>

Edited by Elizabeth A. Martin and Tanya A. McFerran.

in A Dictionary of Nursing

January 2014; p ublished online May 2014 .

Reference Entry. Subjects: Nursing Studies. 19 words.

a drug administered by mouth or injection to treat supraventricular and ventricular arrhythmias. Trade name: Rythmodan.

Go to Oxford Reference »  home page

disopyramide <i>n.</i>

Elizabeth Martin and Tanya McFerran.

in A Dictionary of Nursing

January 2008; p ublished online January 2008 .

Reference Entry. Subjects: Nursing Studies. 22 words.

a drug administered by mouth or injection to treat various heart conditions involving abnormal heart rates. Trade name: Rythmodan.

Go to Oxford Reference »  home page

disopyramide <i>n.</i>

Edited by Elizabeth A. Martin and Tanya A. McFerran.

in A Dictionary of Nursing

May 2017; p ublished online May 2017 .

Reference Entry. Subjects: Nursing. 23 words.

a drug administered by mouth, intravenous injection, or infusion to treat supraventricular and ventricular arrhythmias. Trade name: Rythmodan.

Go to Oxford Reference »  home page

disopyramide <i>n.</i>

Edited by Elizabeth Martin.

in Concise Medical Dictionary

January 2015; p ublished online September 2015 .

Reference Entry. Subjects: Medicine and Health. 42 words.

an *anti-arrhythmic drug used to treat supraventricular and ventricular arrhythmias. It is administered by mouth or by intravenous injection or infusion; side-effects such as dry mouth,...

Go to Oxford Reference »  home page

Increased AAI mode pacing threshold after termination of atrial fibrillation by acute administration of disopyramide phosphate

R. Anzawa, S. Ishikawa, Y. Tanaka, F. Okazaki and S. Mochizuki.

in EP Europace

May 2006; p ublished online May 2006 .

Journal Article. Subjects: Cardiovascular Medicine. 2085 words.

Aims We studied changes in atrial pacing threshold after termination of atrial fibrillation (AF) by acute administration of disopyramide phosphate (DP) to elucidate the...

Go to Oxford Journals »  abstract

Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report

Shintaro Haruki, Yuichiro Minami, Katsuya Kajimoto, Bun Yashiro, Tsuyoshi Suzuki, Masatoshi Kawana and Nobuhisa Hagiwara.

in European Journal of Heart Failure

January 2010; p ublished online November 2009 .

Journal Article. Subjects: Cardiovascular Medicine. 1611 words.

It remains unclear whether the combination of dual-chamber (DDD) pacing and disopyramide can achieve prolonged left ventricular outflow tract (LVOT) gradient reduction and symptom relief in...

Go to Oxford Journals »  abstract

Sinus node recovery time assessment by the overdrive suppression test employing an intravenous injection of disopyramide phosphate

T. Ishikawa, S. Sumita, K. Kimura, M. Kikuchi, M. Kosuge, T. Endo, T. Sugano, T. Sigemasa, T. Usui and S. Umemura.

in EP Europace

January 2000; p ublished online January 2000 .

Journal Article. Subjects: Cardiovascular Medicine. 0 words.

Although sinus node recovery time (SNRT) assessment by the overdrive suppression test (ODST) is important in detecting sick sinus syndrome (SSS), its sensitivity is still inadequate. We...

Go to Oxford Journals »  abstract

Disopyramide Cross-Reactivity in a Commercial Immunoassay Reagent for Methadone

Paul Moorman, Marcia McCoy, Bonnie Hague and Debbie Huge.

in Journal of Analytical Toxicology

July 1999; p ublished online July 1999 .

Journal Article. Subjects: Medical Toxicology; Toxicology (Non-medical). 0 words.

Go to Oxford Journals »  abstract

anti-arrhythmic <i>n.</i>

Edited by Elizabeth A. Martin and Tanya A. McFerran.

in A Dictionary of Nursing

May 2017; p ublished online May 2017 .

Reference Entry. Subjects: Nursing. 31 words.

any of a group of drugs used to correct irregularities in the heartbeat (see arrhythmia). They include adenosine, amiodarone, verapamil, disopyramide, and lidocaine....

Go to Oxford Reference »  home page

Antiarrhythmics

Gaurav Malhotra.

in Pharmacology in Anesthesia Practice

January 2013; p ublished online September 2013 .

Chapter. Subjects: Anaesthetics; Clinical Pharmacology and Therapeutics. 3905 words.

This chapter discusses Antiarrhythmics, including Pharmacodynamics, and covers Quinidine, Procainamide, Disopyramide, Lidocaine, Tocainide, Mexiletine, Flecainide, Propafenone, Amiodarone,...

Go to Oxford Medicine Online »  abstract

anti-arrhythmic

Overview page. Subjects: Clinical Pharmacology and Therapeutics.

(anti-ă-rith-mik)

any of a group of drugs used to correct irregularities in the heartbeat (see arrhythmia). They include adenosine, amiodarone, quinidine, verapamil, disopyramide,...

See overview in Oxford Index

Ventricular tachycardia with congenital left ventricular aneurysm in an adult

Satoshi Yamashiro, Yukio Kuniyoshi, Kazuhumi Miyagi and Kageharu Koja.

in Interactive CardioVascular and Thoracic Surgery

March 2003; p ublished online March 2003 .

Journal Article. Subjects: Professional Development in Medicine; Cardiothoracic Surgery; Cardiovascular Medicine. 1219 words.

A 60-year-old woman without any risk factors for coronary artery disease presented with symptomatic, recurrent, non-sustained ventricular tachycardia. She was found to have a...

Go to Oxford Journals »  abstract

Metabolic Abnormalities and Drugs

Chris J. Rowan.

in Ellestad's Stress Testing

October 2018; p ublished online November 2018 .

Chapter. Subjects: Clinical Medicine; Cardiovascular Medicine. 14714 words.

The chapter Metabolic Abnormalities and Drugs reviews the changes that affect the electrocardiogram at rest and during exercise. Anticipating these changes often allows the exercise test to...

Go to Oxford Medicine Online »  abstract

P.1. Supraventricular Arrhythmias

T. Otsuka, M. Igarashi, N. Fujino, R. Nakanishi, K. Takamura, K. Kobayashi, Y. Okano, H. Masabayashi and J. Yamasaki.

in EP Europace

October 2005; p ublished online October 2005 .

Journal Article. Subjects: Cardiovascular Medicine. 0 words.

Double ventricular response (DVR) was found to induce atrioventricular reentrant tachycardia or atrioventricular nodal reentrant tachycardia. We experienced a rare case with antegrade dual...

Go to Oxford Journals »  abstract

NIP-141, a multiple ion channel blocker, terminates aconitine-induced atrial fibrillation and prevents the rapid pacing-induced atrial effective refractory period shortening in dogs

Norio Hashimoto, Toru Yamashita, Naoki Fujikura and Nobutomo Tsuruzoe.

in EP Europace

April 2007; p ublished online March 2007 .

Journal Article. Subjects: Cardiovascular Medicine. 3427 words.

Aims NIP-141 is a novel multiple ion channel blocker with atrial selective effects. In this study, we examined the effects of NIP-141 on aconitine-induced atrial fibrillation...

Go to Oxford Journals »  abstract

Is there a place for the late cardioversion of atrial fibrillation?. A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation

H Nakazawa, D.A Lythall, J Noh, N Ishikawa, K Sugino, K Ito and S.M.C Hardman.

in European Heart Journal

February 2000; p ublished online February 2000 .

Journal Article. Subjects: Cardiovascular Medicine. 0 words.

Aims As atrial fibrillation is associated with significant mortality and morbidity, restoration of sinus rhythm is desirable. However, previous data suggest that cardioversion...

Go to Oxford Journals »  abstract

Pharmacological therapy for hypertrophic cardiomyopathy: what is the evidence for success?

L. Rydén and F. Gadler.

in European Heart Journal Supplements

October 2001; p ublished online October 2001 .

Journal Article. Subjects: Cardiovascular Medicine. 0 words.

The available experience from studies of pharmacological treatment of patients with hypertrophic cardiomyopathy was mainly gained in selected patient samples, with severe symptoms or a...

Go to Oxford Journals »  abstract